Bulletin from the Extraordinary General Meeting in Oncopeptides AB (publ)
Stockholm —December 4, 2020 — Oncopeptides AB (Nasdaq Stockholm, ONCO), announces that an Extraordinary General Meeting was held today. Due to the extraordinary situation as a result of the COVID-19 pandemic, the extraordinary general meeting was carried out through postal voting, without any physical attendance. At the Extraordinary General Meeting, the following principal resolutions were passed.· It was resolved, in accordance with the Board of Directors’ proposal, to introduce a long term performance based incentive program for the Company’s employees in the US (“US Co-worker LTIP 2020”)